
Sign up to save your podcasts
Or
Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry.
Today we discuss:
- What the science says about the effectiveness of anti-depressants.
- Evidence based principles for prescribing anti-depressants safely.
- Common side effects and withdrawal symptoms.
- Do anti-depressants work via so called "emotional numbing" effects?
- The use of anti-depressants for other conditions such as OCD and PTSD.
- Emerging treatments for depression such as ketamine and psilocybin.
- New treatments for psychosis such as KarXT (Cobenfy).
Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.
If you would like to invite Alex to speak at your organisation please email [email protected] with "Speaking Enquiry" in the subject line.
Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - [email protected] with "Coaching" in the subject line.
Give feedback here - [email protected] -
Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast
Give feedback here - [email protected] Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast
4.6
1414 ratings
Professor David Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at KCL. David is the Editor-in-Chief of the journal Therapeutic Advances in Psychopharmacology. Professor Taylor has been the lead author of the Maudsley Prescribing Guidelines since their inception in 1993. David has also authored over 375 clinical papers in journals such as the Lancet, BMJ, JAMA Psychiatry, British Journal of Psychiatry and Journal of Clinical Psychiatry.
Today we discuss:
- What the science says about the effectiveness of anti-depressants.
- Evidence based principles for prescribing anti-depressants safely.
- Common side effects and withdrawal symptoms.
- Do anti-depressants work via so called "emotional numbing" effects?
- The use of anti-depressants for other conditions such as OCD and PTSD.
- Emerging treatments for depression such as ketamine and psilocybin.
- New treatments for psychosis such as KarXT (Cobenfy).
Interviewed by Dr. Alex Curmi. Dr. Alex is a consultant psychiatrist and a UKCP registered psychotherapist in-training.
If you would like to invite Alex to speak at your organisation please email [email protected] with "Speaking Enquiry" in the subject line.
Alex is not currently taking on new psychotherapy clients, if you are interested in working with Alex for focused behaviour change coaching , you can email - [email protected] with "Coaching" in the subject line.
Give feedback here - [email protected] -
Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast Tiktok - @thinking.mind.podcast
Give feedback here - [email protected] Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast
143 Listeners
191 Listeners
60 Listeners
2,472 Listeners
1,382 Listeners
1,336 Listeners
293 Listeners
151 Listeners
580 Listeners
469 Listeners
719 Listeners
12 Listeners
127 Listeners
178 Listeners
138 Listeners